165 related articles for article (PubMed ID: 30651922)
1. Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after
Cheung KS; Leung WK
Oncotarget; 2018 Dec; 9(97):36891-36893. PubMed ID: 30651922
[TBL] [Abstract][Full Text] [Related]
2. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
J Natl Cancer Inst; 2018 Jul; 110(7):743-749. PubMed ID: 29361002
[TBL] [Abstract][Full Text] [Related]
4. Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory-wide study.
Li B; Cheung KS; Wong IY; Leung WK; Law S
Cancer; 2021 Jun; 127(11):1805-1815. PubMed ID: 33471380
[TBL] [Abstract][Full Text] [Related]
5. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
6. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication.
Arai J; Miyawaki A; Aoki T; Niikura R; Hayakawa Y; Fujiwara H; Ihara S; Fujishiro M; Kasuga M
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1217-1225.e6. PubMed ID: 38354970
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Increases Risk of Gastric Cancer After
Cheung KS; Chan EW; Chen L; Seto WK; Wong ICK; Leung WK
Diabetes Care; 2019 Sep; 42(9):1769-1775. PubMed ID: 31296646
[TBL] [Abstract][Full Text] [Related]
8. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
[TBL] [Abstract][Full Text] [Related]
9. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong IC; Leung WK
Gut; 2020 Mar; 69(3):445-452. PubMed ID: 31101690
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers are associated with lower gastric cancer risk: A territory-wide study with propensity score analysis.
Li B; Cheung KS; Wong IY; Leung WK; Law S
Int J Cancer; 2021 May; 148(9):2148-2157. PubMed ID: 33152125
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study.
Jiang F; Guo CG; Cheung KS; Leung WK
Aliment Pharmacol Ther; 2021 Nov; 54(9):1162-1169. PubMed ID: 34528716
[TBL] [Abstract][Full Text] [Related]
12. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after
Arai J; Niikura R; Hayakawa Y; Sato H; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Suzuki N; Tsuji Y; Yamada A; Koike K
JGH Open; 2021 Jul; 5(7):770-777. PubMed ID: 34263071
[TBL] [Abstract][Full Text] [Related]
14. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
15. Use of proton pump inhibitors for the risk of gastric cancer.
Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors after
Shimada F; Endo H; Takamori A; Matsunaga T; Fujimoto S; Shirai S; Kakiuchi T; Akutagawa T; Sakata Y; Node K; Yamanouchi K; Nakamura S; Fujimoto K; Esaki M
JGH Open; 2021 Nov; 5(11):1284-1288. PubMed ID: 34816014
[TBL] [Abstract][Full Text] [Related]
17. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
18. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
Sezgin O; Aydın MK; Özdemir AA; Kanık AE
Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
[TBL] [Abstract][Full Text] [Related]
19. Risk of gastric cancer development after eradication of Helicobacter pylori.
Cheung KS; Leung WK
World J Gastrointest Oncol; 2018 May; 10(5):115-123. PubMed ID: 29770171
[No Abstract] [Full Text] [Related]
20. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
Oura H; Matsumura T; Kawasaki Y; Okimoto K; Ishikawa K; Kaneko T; Tokunaga M; Oike T; Imai Y; Yokoyama Y; Akizue N; Maruoka D; Ohta Y; Saito K; Nakagawa T; Arai M; Kato J; Kato N
Scand J Gastroenterol; 2020 Feb; 55(2):209-215. PubMed ID: 32008404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
